May 24, 2000Morton Grove Pharmaceuticals
Recalls Phosphate Topical Solution
Grove, IL (SafetyAlerts) - The Food
and Drug Administration (FDA) today reported that Morton Grove Pharmaceuticals is
conducting a recall of Clindamycin Phosphate Topical Solution, USP, 1%, because of one
degradant exceeded specification during stability testing.
The recalled Clindamycin Phosphate
Topical Solution is packaged in 1-fluid ounce bottles - NDC #60432-693-30
and 2-fluid ounce bottles - NDC #60432-693-60. This recall affects Lot Numbers:
21796 and 22334.
FDA stated in its report that over
8,000 bottles were distributed nationwide. The firm estimated that less than 20
percent of the product remained.
This ongoing Class III recall
was initiated by the company, by letter dated April 7, 2000. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-341-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 24, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.